BHCMID

Bausch Health Companies Inc.

HealthcareDrug Manufacturers - Specialty & Generic
$5.73
$0.00(+1.33%)
52W$4.41
$8.69
Updated May 7, 12:00 AM
RSI52
RS Rating28/99
Beta1.02
Volatility50%
F-Score7/9
Mkt Cap$2.1B
WEAKENING

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

WEAKENING

Bausch Health Companies Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 28), showing significant lag compared to the market leaders. Earnings contraction of 23% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.

Relative Strength
28
out of 99
Lagging
Trend Score
1/4
Minervini Criteria
WEAKENING
Risk (Beta)
1.02
vs S&P 500
MARKET
52W Position
31%
from 52W low
Lower Half
Trend & Momentum Analysis

Trend Template (Minervini)

WEAKENING1/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$5.47
50 SMA > 100 SMA$6.02
100 SMA > 150 SMA$6.17
150 SMA > 200 SMA$6.35

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$5.69+0.70%ABOVE
50 SMA$5.47+4.64%ABOVE
100 SMA$6.02-4.92%BELOW
150 SMA$6.17-7.20%BELOW
200 SMA$6.35-9.88%BELOW

Price Performance

1D+1.3%
1W+0.1%
1M+8.8%
3M-4.3%
6M-13.9%
YTD-20.6%
1Y+21.8%
3Y-1.5%
52-Week Trading Range31% from low
$5.72
52W Low$4.41
52W High$8.69

Technical Indicators

RSI (14)NEUTRAL
52.3
305070
VCP ScoreCOOL
4/10
Base depth: 24.5%

Risk Profile

Beta
1.02
52W Vol
50%
ATR
$0.23
Max DD (1Y)
-41%

Volume Analysis

Today
1.88M
50D Avg
1.80M
Vol Ratio
1.05x
Liquidity
MODERATE

Earnings Momentum

Q2'25+1381%
$0.40
Q3'25+304%
$0.47
Q4'25-224%
$-0.31
Q1'26-2269%
$-3.79
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:+0.00%
5 Years:+5.41%
3 Years:+8.74%
TTM:+8.52%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-27.58%

Stock Price CAGR

10 Years:-14.70%
5 Years:-27.24%
3 Years:-1.50%
1 Year:+21.81%

Return on Equity

10Y Avg:-95.2%
5Y Avg:-152.0%
3Y Avg:-38.5%
Last Year:588.2%

Key Metrics

Market Cap$2.1B
Gross Margin60.9%
Net Margin1.5%
Piotroski F-Score7/9

Frequently Asked Questions

Is BHC in an uptrend right now?

BHC has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.

Is BHC overbought or oversold?

BHC's RSI (14) is 52. The stock is in neutral territory, neither overbought nor oversold.

Is BHC outperforming the market?

BHC has a Relative Strength (RS) Rating of 28 out of 99. BHC is currently lagging the broader market.

Where is BHC in its 52-week range?

BHC is trading at $5.72, which is 66% of its 52-week high ($8.69) and 31% above its 52-week low ($4.41).

How volatile is BHC?

BHC has a Beta of 1.02 and 52-week volatility of 50%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.